BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLT
3101
DELISTED
Applied Therapeutics
APLT
| $27.3M | ﹤0.01% |
1,312,102
+108,372
| +9% | +$2.05M |
|
3102
Citizens & Northern Corp
CZNC
$454M
| $27.2M | ﹤0.01% |
1,111,778
+3,353
| +0.3% | +$82.4K |
|
3103
SoundThinking
SSTI
$108M
| $27.2M | ﹤0.01% |
557,313
-32,428
| -5% | -$1.24M |
|
3104
Canadian Natural Resources
CNQ
$96.5B
| $27.2M | ﹤0.01% |
1,529,080
+2,401
| +0.2% | +$39.5K |
|
3105
ARS Pharmaceuticals
SPRY
$525M
| $27.2M | ﹤0.01% |
879,365
-339,903
| -28% | -$10.9M |
|
|
IMDX
3106
Insight Molecular Diagnostics
IMDX
$167M
| $27.1M | ﹤0.01% |
236,486
-11,925
| -5% | -$1.16M |
|
3107
Kodak
KODK
$955M
| $27.1M | ﹤0.01% |
3,262,139
+1,080,507
| +50% | +$8.48M |
|
|
AEVA
3108
Aeva Technologies
AEVA
$1.34B
| $27.1M | ﹤0.01% |
+512,329
| New | +$25.9M |
|
3109
Evolus
EOLS
$406M
| $26.9M | ﹤0.01% |
2,127,366
+446,255
| +27% | +$4.91M |
|
|
GOOS
3110
Canada Goose Holdings
GOOS
$874M
| $26.7M | ﹤0.01% |
610,892
+470,935
| +336% | +$19.2M |
|
3111
TriSalus Life Sciences
TLSI
$292M
| $26.7M | ﹤0.01% |
2,750,000
| – | – |
|
|
RPT
3112
Rithm Property Trust
RPT
$94.7M
| $26.7M | ﹤0.01% |
342,358
-1,495
| -0.4% | -$110K |
|
|
BDSI
3113
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $26.7M | ﹤0.01% |
7,444,242
-1,144,355
| -13% | -$4.04M |
|
3114
iShares MSCI Italy ETF
EWI
$1.07B
| $26.5M | ﹤0.01% |
+819,659
| New | +$26.8M |
|
3115
Civista Bancshares
CIVB
$600M
| $26.5M | ﹤0.01% |
1,198,641
-74,424
| -6% | -$1.72M |
|
3116
Old Second Bancorp
OSBC
$1.32B
| $26.5M | ﹤0.01% |
2,135,566
-200,465
| -9% | -$2.68M |
|
3117
Quantum Corp
QMCO
$446M
| $26.5M | ﹤0.01% |
192,117
+63,599
| +49% | +$10.3M |
|
3118
UroGen Pharma
URGN
$2.1B
| $26.4M | ﹤0.01% |
1,727,039
+56,434
| +3% | +$1.02M |
|
|
LX
3119
LexinFintech Holdings
LX
$242M
| $26.3M | ﹤0.01% |
2,145,686
+88,961
| +4% | +$901K |
|
3120
Energy Transfer Partners
ET
$69.6B
| $26.3M | ﹤0.01% |
2,470,892
-1,317,376
| -35% | -$12.6M |
|
3121
Black Diamond Therapeutics
BDTX
$103M
| $26.3M | ﹤0.01% |
2,154,212
+223,627
| +12% | +$4.42M |
|
3122
Allient
ALNT
$1.61B
| $26.3M | ﹤0.01% |
760,208
-39,332
| -5% | -$1.38M |
|
3123
Invesco S&P 500 Equal Weight ETF
RSP
$99.6B
| $26.2M | ﹤0.01% |
173,627
-51
| -0% | -$7.59K |
|
3124
PUT
ARK Innovation ETF
ARKK
$6.08B
| $26.2M | ﹤0.01% |
200,000
-285,000
| -59% | -$33.2M |
|
|
AWH
3125
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $26.1M | ﹤0.01% |
309,790
-58,510
| -16% | -$5.03M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.